Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, United States.
Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, United States.
Bioorg Med Chem. 2020 Feb 15;28(4):115301. doi: 10.1016/j.bmc.2019.115301. Epub 2020 Jan 7.
A new non-cytotoxic [(+)-17β-hydroxystrebloside (1)] and two known cytotoxic [(+)-3'-de-O-methylkamaloside (2) and (+)-strebloside (3)] cardiac glycosides were isolated and identified from the combined flowers, leaves, and twigs of Streblus asper collected in Vietnam, with the absolute configuration of 1 established from analysis of its ECD and NMR spectroscopic data and confirmed by computational ECD calculations. A new 14,21-epoxycardanolide (3a) was synthesized from 3 that was treated with base. A preliminary structure-activity relationship study indicated that the C-14 hydroxy group and the C-17 lactone unit and the established conformation are important for the mediation of the cytotoxicity of 3. Molecular docking profiles showed that the cytotoxic 3 and its non-cytotoxic analogue 1 bind differentially to Na/K-ATPase. Compound 3 docks deeply in the Na/K-ATPase pocket with a sole pose, and its C-10 formyl and C-5, C-14, and C-4' hydroxy groups may form hydrogen bonds with the side-chains of Glu111, Glu117, Thr797, and Arg880 of Na/K-ATPase, respectively. However, 1 fits the cation binding sites with at least three different poses, which all depotentiate the binding between 1 and Na/K-ATPase. Thus, 3 was found to inhibit Na/K-ATPase, but 1 did not. In addition, the cytotoxic and Na/K-ATPase inhibitory 3 did not affect glucose uptake in human lung cancer cells, against which it showed potent activity, indicating that this cardiac glycoside mediates its cytotoxicity by targeting Na/K-ATPase but not by interacting with glucose transporters.
从越南采集的棘叶榕(Streblus asper)的花、叶和小枝的混合物中分离并鉴定出一种新的非细胞毒性 [(+)-17β-羟基甾醇苷(1)] 和两种已知的细胞毒性 [(+)-3'-去-O-甲基卡马醇苷(2) 和 (+)-甾醇苷(3)] 糖苷,1 的绝对构型是通过分析其 ECD 和 NMR 光谱数据确定的,并通过计算 ECD 计算得到证实。3 用碱处理得到一种新的 14,21-环氧卡醇内酯 (3a)。初步的构效关系研究表明,C-14 羟基和 C-17 内酯单元以及确定的构象对于介导 3 的细胞毒性很重要。分子对接谱表明,细胞毒性 3 及其非细胞毒性类似物 1 与 Na/K-ATP 酶的结合方式不同。化合物 3 仅以一种构象深嵌入 Na/K-ATP 酶口袋中,其 C-10 甲酰基和 C-5、C-14 和 C-4' 羟基可能分别与 Na/K-ATP 酶的 Glu111、Glu117、Thr797 和 Arg880 的侧链形成氢键。然而,1 与阳离子结合位点结合至少有三种不同的构象,这三种构象都使 1 与 Na/K-ATP 酶的结合减弱。因此,发现 3 抑制 Na/K-ATP 酶,但 1 没有。此外,细胞毒性和 Na/K-ATP 酶抑制 3 并不影响人肺癌细胞的葡萄糖摄取,而对其表现出很强的活性,表明这种强心苷通过靶向 Na/K-ATP 酶而不是通过与葡萄糖转运体相互作用来介导其细胞毒性。